Stoke Therapeutics, Inc. (STOK)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 11.69 |
| 開市 | 12.00 |
| 買盤 | 11.97 x 400 |
| 賣出價 | 12.07 x 300 |
| 今日波幅 | 11.59 - 12.60 |
| 52 週波幅 | 3.35 - 16.40 |
| 成交量 | |
| 平均成交量 | 1,313,085 |
| 市值 | 626.452M |
| Beta 值 (5 年，每月) | 0.76 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.38 |
| 業績公佈日 | 2024年8月05日 - 2024年8月09日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 23.67 |
ZacksEarnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline
Axsome (AXSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksEarnings Preview: Stoke Therapeutics, Inc. (STOK) Q1 Earnings Expected to Decline
Stoke Therapeutics (STOK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksStoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data
Stoke Therapeutics (STOK) gains on meaningful clinical data from STK-001 studies for the treatment of Dravet syndrome.
